Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P Miller
OpenAlex ID:
A5052154990
EE572 Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgavimab) for Pre-exposure Prophylaxis Against COVID-19 in the Immunocompromised Population
2022
·
K Sutton
, P Miller
, et al.
·
Value in Health
·
1
PDF
Show more works
View as search
Works count:
1
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
